NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE
Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs. Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favor...
Gespeichert in:
Veröffentlicht in: | Acta endocrinologica (Bucharest, Romania : 2005) Romania : 2005), 2018-04, Vol.14 (2), p.255-260 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 260 |
---|---|
container_issue | 2 |
container_start_page | 255 |
container_title | Acta endocrinologica (Bucharest, Romania : 2005) |
container_volume | 14 |
creator | Dirilenoglu, F Kahraman Akkalp, A Bag, H Atasever Rezanko, T Kucukodaci, Z |
description | Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs.
Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favorable outcome.
We have documented a rare case of an NE-ATC with its clinical, pathological, and molecular features. We also provided a thorough discussion of all the encapsulated ATCs reported in the literature.
A 50-year-old woman with an unremarkable medical history, who presented with a thyroid nodule, and diagnosed as "follicular lesion of undetermined significance" by fine needle aspiration biopsy. The patient was lost to follow-up for six years and revisited upon her neck disturbances and underwent total thyroidectomy.
Sections of the right lobe revealed a grossly encapsulated nodular lesion, measuring 75x55x55 mm. Histologically, the tumor consisted of both carcinomatous and sarcomatous components supported by immunohistochemical stains. Necrosis and atypical mitotic figures were evident. Capsular and/or vascular invasion was not identified. There were no BRAF codon 600, KRAS, NRAS mutations and RET/PTC rearrangement. During three-month follow-up, the patient was free of disease without adjuvant therapy.
Encapsulated ATCs tend to follow a favorable clinical course and may deserve conservative treatment approaches. |
doi_str_mv | 10.4183/aeb.2018.255 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6516515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31149267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c308t-35b9fbc0e649c6375596ecf5dd5196cd85d75d3a832e4093cf1aeee9a37643c93</originalsourceid><addsrcrecordid>eNpVkdtKxDAQhoMonu-8ljyAXZNNkzZeCCEbNVDTpe2uehW6aaorriutCr6Bj23WEwoDMzD_fHPxAXCA0SDGKTmu_WwwRDgdDCldA9s4jUmEGLte_5xxhHiabIGdvr9HiKYI402wRTCO-ZAl2-Dd5EabqSj1VEFlpBiXk0xUagSFEeNMlJWWsLq4KXI9glIUUpv8UsBxkV_qUpvzEIPqWqosU6aCMtNGS5FBmU-KUp1AEW5KBQs1zosqZEdhnGp1BfOzQFUw05UqRDUp1B7YaOuH3u9_910wOVOVvIiy_HyFjBxB6XNE6Iy3M4c8i7ljJKGUM-9a2jQUc-aalDYJbUidkqGPESeuxbX3ntckYTFxnOyC0y_u08ts4RvnH5-7-sE-dfNF3b3ZZT23_zeP8zt7u3y1jOJQNACOvgCuW_Z959vfW4zsyogNRuzKiA1GQvzw77_f8I8C8gHLZX33</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Dirilenoglu, F ; Kahraman Akkalp, A ; Bag, H ; Atasever Rezanko, T ; Kucukodaci, Z</creator><creatorcontrib>Dirilenoglu, F ; Kahraman Akkalp, A ; Bag, H ; Atasever Rezanko, T ; Kucukodaci, Z</creatorcontrib><description>Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs.
Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favorable outcome.
We have documented a rare case of an NE-ATC with its clinical, pathological, and molecular features. We also provided a thorough discussion of all the encapsulated ATCs reported in the literature.
A 50-year-old woman with an unremarkable medical history, who presented with a thyroid nodule, and diagnosed as "follicular lesion of undetermined significance" by fine needle aspiration biopsy. The patient was lost to follow-up for six years and revisited upon her neck disturbances and underwent total thyroidectomy.
Sections of the right lobe revealed a grossly encapsulated nodular lesion, measuring 75x55x55 mm. Histologically, the tumor consisted of both carcinomatous and sarcomatous components supported by immunohistochemical stains. Necrosis and atypical mitotic figures were evident. Capsular and/or vascular invasion was not identified. There were no BRAF codon 600, KRAS, NRAS mutations and RET/PTC rearrangement. During three-month follow-up, the patient was free of disease without adjuvant therapy.
Encapsulated ATCs tend to follow a favorable clinical course and may deserve conservative treatment approaches.</description><identifier>ISSN: 1841-0987</identifier><identifier>EISSN: 1843-066X</identifier><identifier>DOI: 10.4183/aeb.2018.255</identifier><identifier>PMID: 31149267</identifier><language>eng</language><publisher>Romania: Acta Endocrinologica Foundation</publisher><subject>Case Report</subject><ispartof>Acta endocrinologica (Bucharest, Romania : 2005), 2018-04, Vol.14 (2), p.255-260</ispartof><rights>by Acta Endocrinologica Foundation 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516515/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516515/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31149267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dirilenoglu, F</creatorcontrib><creatorcontrib>Kahraman Akkalp, A</creatorcontrib><creatorcontrib>Bag, H</creatorcontrib><creatorcontrib>Atasever Rezanko, T</creatorcontrib><creatorcontrib>Kucukodaci, Z</creatorcontrib><title>NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE</title><title>Acta endocrinologica (Bucharest, Romania : 2005)</title><addtitle>Acta Endocrinol (Buchar)</addtitle><description>Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs.
Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favorable outcome.
We have documented a rare case of an NE-ATC with its clinical, pathological, and molecular features. We also provided a thorough discussion of all the encapsulated ATCs reported in the literature.
A 50-year-old woman with an unremarkable medical history, who presented with a thyroid nodule, and diagnosed as "follicular lesion of undetermined significance" by fine needle aspiration biopsy. The patient was lost to follow-up for six years and revisited upon her neck disturbances and underwent total thyroidectomy.
Sections of the right lobe revealed a grossly encapsulated nodular lesion, measuring 75x55x55 mm. Histologically, the tumor consisted of both carcinomatous and sarcomatous components supported by immunohistochemical stains. Necrosis and atypical mitotic figures were evident. Capsular and/or vascular invasion was not identified. There were no BRAF codon 600, KRAS, NRAS mutations and RET/PTC rearrangement. During three-month follow-up, the patient was free of disease without adjuvant therapy.
Encapsulated ATCs tend to follow a favorable clinical course and may deserve conservative treatment approaches.</description><subject>Case Report</subject><issn>1841-0987</issn><issn>1843-066X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkdtKxDAQhoMonu-8ljyAXZNNkzZeCCEbNVDTpe2uehW6aaorriutCr6Bj23WEwoDMzD_fHPxAXCA0SDGKTmu_WwwRDgdDCldA9s4jUmEGLte_5xxhHiabIGdvr9HiKYI402wRTCO-ZAl2-Dd5EabqSj1VEFlpBiXk0xUagSFEeNMlJWWsLq4KXI9glIUUpv8UsBxkV_qUpvzEIPqWqosU6aCMtNGS5FBmU-KUp1AEW5KBQs1zosqZEdhnGp1BfOzQFUw05UqRDUp1B7YaOuH3u9_910wOVOVvIiy_HyFjBxB6XNE6Iy3M4c8i7ljJKGUM-9a2jQUc-aalDYJbUidkqGPESeuxbX3ntckYTFxnOyC0y_u08ts4RvnH5-7-sE-dfNF3b3ZZT23_zeP8zt7u3y1jOJQNACOvgCuW_Z959vfW4zsyogNRuzKiA1GQvzw77_f8I8C8gHLZX33</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Dirilenoglu, F</creator><creator>Kahraman Akkalp, A</creator><creator>Bag, H</creator><creator>Atasever Rezanko, T</creator><creator>Kucukodaci, Z</creator><general>Acta Endocrinologica Foundation</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180401</creationdate><title>NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE</title><author>Dirilenoglu, F ; Kahraman Akkalp, A ; Bag, H ; Atasever Rezanko, T ; Kucukodaci, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c308t-35b9fbc0e649c6375596ecf5dd5196cd85d75d3a832e4093cf1aeee9a37643c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dirilenoglu, F</creatorcontrib><creatorcontrib>Kahraman Akkalp, A</creatorcontrib><creatorcontrib>Bag, H</creatorcontrib><creatorcontrib>Atasever Rezanko, T</creatorcontrib><creatorcontrib>Kucukodaci, Z</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dirilenoglu, F</au><au>Kahraman Akkalp, A</au><au>Bag, H</au><au>Atasever Rezanko, T</au><au>Kucukodaci, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE</atitle><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle><addtitle>Acta Endocrinol (Buchar)</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>14</volume><issue>2</issue><spage>255</spage><epage>260</epage><pages>255-260</pages><issn>1841-0987</issn><eissn>1843-066X</eissn><abstract>Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs.
Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favorable outcome.
We have documented a rare case of an NE-ATC with its clinical, pathological, and molecular features. We also provided a thorough discussion of all the encapsulated ATCs reported in the literature.
A 50-year-old woman with an unremarkable medical history, who presented with a thyroid nodule, and diagnosed as "follicular lesion of undetermined significance" by fine needle aspiration biopsy. The patient was lost to follow-up for six years and revisited upon her neck disturbances and underwent total thyroidectomy.
Sections of the right lobe revealed a grossly encapsulated nodular lesion, measuring 75x55x55 mm. Histologically, the tumor consisted of both carcinomatous and sarcomatous components supported by immunohistochemical stains. Necrosis and atypical mitotic figures were evident. Capsular and/or vascular invasion was not identified. There were no BRAF codon 600, KRAS, NRAS mutations and RET/PTC rearrangement. During three-month follow-up, the patient was free of disease without adjuvant therapy.
Encapsulated ATCs tend to follow a favorable clinical course and may deserve conservative treatment approaches.</abstract><cop>Romania</cop><pub>Acta Endocrinologica Foundation</pub><pmid>31149267</pmid><doi>10.4183/aeb.2018.255</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1841-0987 |
ispartof | Acta endocrinologica (Bucharest, Romania : 2005), 2018-04, Vol.14 (2), p.255-260 |
issn | 1841-0987 1843-066X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6516515 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Case Report |
title | NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A59%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NONINVASIVE%20ENCAPSULATED%20ANAPLASTIC%20THYROID%20CARCINOMA%20PROMISING%20AN%20EXCELLENT%20CLINICAL%20COURSE:%20A%20CASE%20REPORT%20AND%20REVIEW%20OF%20THE%20LITERATURE&rft.jtitle=Acta%20endocrinologica%20(Bucharest,%20Romania%20:%202005)&rft.au=Dirilenoglu,%20F&rft.date=2018-04-01&rft.volume=14&rft.issue=2&rft.spage=255&rft.epage=260&rft.pages=255-260&rft.issn=1841-0987&rft.eissn=1843-066X&rft_id=info:doi/10.4183/aeb.2018.255&rft_dat=%3Cpubmed_cross%3E31149267%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31149267&rfr_iscdi=true |